pH-Responsive copolymer assemblies for controlled release of doxorubicin

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Nanotechnology

Background:

• pH-responsive drug carriers offer targeted release in acidic environments like tumors and intracellular vesicles.
• Acid-sensitive micelles can be designed to disrupt and release drugs upon encountering specific pH levels.

Purpose of the Study:

• To develop novel acid-sensitive micelles for controlled drug release.
• To investigate the pH-triggered release of doxorubicin (DOX) from these micelles.
• To evaluate the in vitro performance and intracellular behavior of the drug-loaded micelles.

Main Methods:

• Incorporation of hydrophobic acetal groups into a micelle-forming block copolymer core.
• Encapsulation of doxorubicin (DOX) into the pH-sensitive micelles.
• Determination of acetal hydrolysis and DOX release rates across a pH range (4.0-7.4).
• Micelle disruption analysis using dynamic light scattering.
• In vitro toxicity assessment and intracellular DOX tracking via fluorescence confocal microscopy.

Main Results:

• The developed micelles demonstrated pH-dependent disruption due to acetal hydrolysis at acidic pH.
• Controlled release of doxorubicin was observed, with faster release rates at lower pH values.
• Dynamic light scattering confirmed micelle disruption.
• In vitro studies showed comparable toxicity of loaded micelles to free DOX, with altered intracellular drug distribution.

Conclusions:

• The novel acetal-containing block copolymer micelles are effective pH-responsive drug delivery systems.
• These micelles facilitate triggered drug release in acidic conditions, relevant for tumor targeting.
• The findings support the potential of these carriers for enhanced cancer therapy.